Michaela B Kirschner

Citée par

	Toutes	Depuis 2019
Citations	3167	1625
indice h	23	20
indice i10	30	30

380

190

285

2011201220132014201520162017201820192020202120222023202421 47 118 187 269 242 319 319 327 364 329 304 229 72

Accès public

Tout afficher

10 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Glen ReidThe University of OtagoAdresse e-mail validée de otago.ac.nz
Nico van ZandwijkProfessor Emeritus University of SydneyAdresse e-mail validée de sydney.edu.au
J James EdelmanUniversity of Western AustraliaAdresse e-mail validée de health.wa.gov.au
Michael Vallely PhD, FRACSThe Ohio State University Wexner Medical CenterAdresse e-mail validée de osumc.edu
Casey M WrightUniversity of Queensland, Diamantina InstituteAdresse e-mail validée de uqconnect.edu.au
Nicola ArmstrongCurtin UniversityAdresse e-mail validée de curtin.edu.au
Ruby CY LinWestmead Institute for Medical ResearchAdresse e-mail validée de unsw.edu.au
Stephen ClarkeProfessor of Medicine, University of Sydney and Medical Oncologist, RNSH and Genesis CareAdresse e-mail validée de sydney.edu.au
Bruce Robinsonuniversity of western austRALIAAdresse e-mail validée de uwa.edu.au
Steven G. GraySt James's Hospital & Trinity College DublinAdresse e-mail validée de stjames.ie
emanuela felley-boscoLaboratory of Molecular OncologyAdresse e-mail validée de usz.ch
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalAdresse e-mail validée de sswahs.nsw.gov.au
Jason MadoreQueensland Institute of Medical ResearchAdresse e-mail validée de qimrberghofer.edu.au
Mark P MolloyThe University of SydneyAdresse e-mail validée de sydney.edu.au
Rolf StahelOncology, University of ZüruchAdresse e-mail validée de usz.ch
Dominic NgAssociate Professor, School of Biomedical Science, University of QueenslandAdresse e-mail validée de uq.edu.au
Michele CarboneUniversity of HawaiiAdresse e-mail validée de cc.hawaii.edu
Giovanni GaudinoProfessor at University of Hawai'i Cancer CenterAdresse e-mail validée de hawaii.edu
Andrea NapolitanoRoyal Marsden Hospital, LondonAdresse e-mail validée de rmh.nhs.uk
Y C Gary LeeProfessor of Respiratory Medicine, University of Western AustraliaAdresse e-mail validée de uwa.edu.au

Suivre

Michaela B Kirschner

UniversityHospital Zurich, Department of Thoracic Surgery

Adresse e-mail validée de usz.ch

Malignant Mesothelioma MicroRNAs Biomarkers


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Circulating microRNAs: Association with disease and potential use as biomarkers G Reid, MB Kirschner, N van Zandwijk Critical reviews in oncology/hematology 80 (2), 193-208, 2011	585	2011
Haemolysis during sample preparation alters microRNA content of plasma MB Kirschner, SC Kao, JJ Edelman, NJ Armstrong, MP Vallely, ... PloS one 6 (9), e24145, 2011	574	2011
The impact of hemolysis on cell-free microRNA biomarkers MB Kirschner, JJB Edelman, SCH Kao, MP Vallely, N Van Zandwijk, ... Frontiers in genetics 4, 94, 2013	378	2013
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma G Reid, ME Pel, MB Kirschner, YY Cheng, N Mugridge, J Weiss, ... Annals of Oncology 24 (12), 3128-3135, 2013	272	2013
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma MB Kirschner, YY Cheng, B Badrian, SC Kao, J Creaney, JJB Edelman, ... Journal of thoracic oncology 7 (7), 1184-1191, 2012	143	2012
Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma SC Kao, YY Cheng, M Williams, MB Kirschner, J Madore, T Lum, ... Journal of Thoracic Oncology 12 (9), 1421-1433, 2017	142	2017
Combined genetic and genealogic studies uncover a large BAP1 cancer syndrome kindred tracing back nine generations to a common ancestor from the 1700s M Carbone, EG Flores, M Emi, TA Johnson, T Tsunoda, D Behner, ... PLoS genetics 11 (12), e1005633, 2015	106	2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma M Williams, MB Kirschner, YY Cheng, J Hanh, J Weiss, N Mugridge, ... Oncotarget 6 (27), 23480, 2015	94	2015
Cell-free microRNAs: potential biomarkers in need of standardized reporting MB Kirschner, N Zandwijk, G Reid Frontiers in genetics 4, 56, 2013	78	2013
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis MB Kirschner, E Pulford, MA Hoda, A Rozsas, K Griggs, YY Cheng, ... British journal of cancer 113 (6), 963-969, 2015	77	2015
MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma MB Kirschner, YY Cheng, NJ Armstrong, RCY Lin, SC Kao, A Linton, ... Molecular oncology 9 (3), 715-726, 2015	74	2015
A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis F Vafaee, C Diakos, MB Kirschner, G Reid, MZ Michael, LG Horvath, ... NPJ systems biology and applications 4 (1), 20, 2018	55	2018
Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma KA Birnie, YY Yip, DCH Ng, MB Kirschner, G Reid, CM Prêle, AW Musk, ... Molecular Cancer Research 13 (7), 1106-1118, 2015	55	2015
KCa1. 1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma YY Cheng, CM Wright, MB Kirschner, M Williams, KH Sarun, V Sytnyk, ... Molecular cancer 15, 1-12, 2016	50	2016
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma A Linton, YY Cheng, K Griggs, MB Kirschner, S Gattani, S Srikaran, ... British journal of cancer 110 (2), 510-519, 2014	50	2014
FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal K Schelch, C Wagner, S Hager, C Pirker, K Siess, E Lang, R Lin, ... Carcinogenesis 39 (4), 534-545, 2018	43	2018
Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma TG Johnson, K Schelch, YY Cheng, M Williams, KH Sarun, MB Kirschner, ... Journal of Thoracic Oncology 13 (2), 258-272, 2018	43	2018
Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM) CM Wright, MB Kirschner, YY Cheng, KJ O'Byrne, SG Gray, K Schelch, ... PloS one 8 (8), e70940, 2013	37	2013
A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma K Schelch, MB Kirschner, M Williams, YY Cheng, N van Zandwijk, ... Molecular oncology 12 (1), 58-73, 2018	35	2018
ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma YY Cheng, MB Kirschner, NC Cheng, S Gattani, S Klebe, JJB Edelman, ... Journal of Thoracic Oncology 8 (10), 1317-1328, 2013	35	2013

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs